COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
批准号:
10224225
负责人:
ELEFTHERIOS MYLONAKIS
金额:
$45.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-18 至 2023-07-31
关键词:
Advisory CommitteesAntimicrobial ResistanceAwardBiological SciencesCenters of Research ExcellenceCommunicationConflict (Psychology)Core FacilityEnsureEnvironmentFacultyFosteringFundingGoalsGrantHospitalsIndividualInfrastructureInstitutionLaboratoriesMentorsMissionMonitorNational Institute of General Medical SciencesOutcomePeer ReviewPerformancePhasePhilosophyProcessPublicationsResearchResearch PersonnelResistance developmentRhode IslandScienceServicesTherapeuticUnited States National Institutes of HealthUniversitiesWorkbasedesigndrug developmentfaculty mentororganizational structureoutreachprofessorprogramssenior faculty
中文摘要
行政核心
总结/摘要
行政核心将提供财政、科学和技术管理,
COBRE抗菌药物耐药性和治疗发现中心(CARTD)
医院核心主任Mylonakis将在副主任Nau的协助下,
总体方案目标。这些目标和实现这些目标的进展将是
由指导委员会,外部咨询委员会,高级教师指导监督
和咨询委员会(SFMAC)和项目工作人员在NIGMS。我们中心的总体使命是
培养一个激励个人追求严格的实验室科学的环境,
通过我们的核心设施提供技术和指导支持。我们将继续
(1)核心将维持一个组织结构,确保
监督、科学、行政和服务导向之间的有效沟通
COBRE的组成部分。(2):核心小组将制定战略,增加CARDT的使用
在第三阶段结束时实现自我维持的核心。(3):核心将提供严格的
为所有CARDT主要/试点调查员提供指导基础设施。(4):核心将管理一个
试点赠款计划,旨在支持最有价值的抗菌研究
耐药性和药物开发。
英文摘要
Administrative Core
Summary/Abstract
The Administrative Core will provide financial, scientific and technologic stewardship of the
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery (CARTD) at The Miriam
Hospital. Core Director Mylonakis, with the assistance of Deputy Director Nau, will establish
overall programmatic goals. These goals and progress toward accomplishing them will be
monitored by the Steering Committee, External Advisory Committee, Senior Faculty Mentoring
and Advisory Committee (SFMAC) and Program Staff at NIGMS. Our Center’s overall mission is
to foster an environment that inspires individuals to pursue rigorous laboratory science by
providing technical and mentoring support through our core facilities. We will pursue the
following specific aims: (1): The Core will maintain an organizational structure that ensures
effective communication between the supervisory, scientific, administrative and service oriented
components of the COBRE. (2): The Core will devise strategies to increase the use of CARDT
Cores to allow self-sustainability by the end of Phase III. (3): The Core will provide a rigorous
mentoring infrastructure to all CARDT principal/pilot investigators. (4): The Core will manage a
Pilot Grants Program designed to support the most meritorious research on antimicrobial
resistance and drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
-
批准号:10224224
-
项目类别:
-
资助金额:$185.87万
-
财政年份:2018
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
ID. of Pathways that can be Targeted for the Develop. of Novel Therapies for MRSA
-
批准号:8376871
-
项目类别:
-
资助金额:$66.6万
-
财政年份:2012
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
ID. of Pathways that can be Targeted for the Develop. of Novel Therapies for MRSA
-
批准号:8202926
-
项目类别:
-
资助金额:$49.48万
-
财政年份:2011
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
Genome-wide investigations in fungal pathogens utilizing an invertebrate model ho
-
批准号:7739081
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2009
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
Genome-wide investigations in fungal pathogens utilizing an invertebrate model ho
-
批准号:7876749
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2009
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
Subproject 2: Identification of Pathways that Can be Targeted for the Development of Novel Therapies for MRSA
-
批准号:10327903
-
项目类别:
-
资助金额:$42.72万
-
财政年份:2009
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
Subproject 2: Identification of Pathways that Can be Targeted for the Development of Novel Therapies for MRSA
-
批准号:10571902
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2009
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
A C.elegans high-throughput assay for the identification of new antifungal agents
-
批准号:7880134
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2008
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
A C.elegans high-throughput assay for the identification of new antifungal agents
-
批准号:7473741
-
项目类别:
-
资助金额:$43.94万
-
财政年份:2008
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
A C.elegans high-throughput assay for the identification of new antifungal agents
-
批准号:7618695
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2008
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
C.elegans as a model system forC.neoformans pathogenesis
-
批准号:7026929
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2005
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
C.elegans as a model system forC.neoformans pathogenesis
-
批准号:7257036
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2005
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
C.elegans as a model system forC.neoformans pathogenesis
-
批准号:6859552
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2005
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
Identification of Pathways that can be Targeted for the Development of Novel Therapies for MRSA
-
批准号:8716644
-
项目类别:
-
资助金额:$47.58万
-
财政年份:--
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
Identification of Pathways that can be Targeted for the Development of Novel Therapies for MRSA
-
批准号:8901910
-
项目类别:
-
资助金额:$52.99万
-
财政年份:--
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
ID. of Pathways that can be Targeted for the Develop. of Novel Therapies for MRSA
-
批准号:8531136
-
项目类别:
-
资助金额:$44.72万
-
财政年份:--
-
负责人:ELEFTHERIOS MYLONAKIS
-
依托单位:
海外基金